Ronald J. Ellis Jr.

Insider

First SEC filing: March 28, 2023 · Latest: March 28, 2023

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 7, 2023	PCRX	S	1,162	$37.86	$43,993	30,909 Direct	-3.62%	Disposed	-36.6% (price as of 2026-08-21)
June 6, 2023	PCRX	S	1,114	$38.99	$43,435	32,071 Direct	-3.36%	Disposed	-38.5% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
March 28, 2023	PCRX	Common Stock	33,185	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (27,100)	27,100	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (15,000)	15,000	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (22,416)	22,416	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (5,708)	5,708	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (13,866)	13,866	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (12,353)	12,353	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (5,030)	5,030	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (1,554)	1,554	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (660)	660	Direct
March 28, 2023	PCRX	Stock Option (Right to Buy)→ Common Stock (3,832)	3,832	Direct